Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know ; day:13 ; month:2 ; year:2020 ; pages:1-13
Neurology and Therapy ; (13.2.2020), 1-13
- Urheber
-
AlJumah, Mohamed
Alkhawajah, Mona Marwan
Qureshi, Shireen
Al-Thubaiti, Ibtisam
Ayoub, Omar
Bohlega, Saeed A.
Bushnag, Areej
Cupler, Edward
Daif, Abdulkader
El Boghdady, Ahmed
Hassan, Ahmed
Al Malik, Yaser
Saeedi, Jameelah
Al-Shamrany, Fawzia
Shosha, Eslam
Rieckmann, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-020-00177-5
- URN
-
urn:nbn:de:101:1-2020051202050861576385
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- AlJumah, Mohamed
- Alkhawajah, Mona Marwan
- Qureshi, Shireen
- Al-Thubaiti, Ibtisam
- Ayoub, Omar
- Bohlega, Saeed A.
- Bushnag, Areej
- Cupler, Edward
- Daif, Abdulkader
- El Boghdady, Ahmed
- Hassan, Ahmed
- Al Malik, Yaser
- Saeedi, Jameelah
- Al-Shamrany, Fawzia
- Shosha, Eslam
- Rieckmann, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relapsing/remitting type 1 diabetes
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis